tirzepatide super obesity bmi 60 lowers body weight for adults with obesity, regardless of disease duration Abstract 4343077: Combination of Prolonged

Hi Andrea, Thats a great questionand one many people wonder about

Adults who meet the eligibility criteria assessed online People ready to pair treatment with healthier eating and activity Those who want ongoing follow-up, not a one-off purchase It is not suitable for everyone

Zepbound qualifies as a medical expense, making pre-tax dollars work for it

Both groups ultimately achieved clinically meaningful results, but the trajectory differed

Across both trials, 4.8%, 6.3%, and 6.7% of patients treated with 5 mg, 10 mg, and 15 mg of ZEPBOUND, respectively, permanently discontinued treatment as a result of adverse reactions compared to 3.4% of patients treated with placebo